Search

Displaying results 4471 - 4480 of 9724 in total
  1. Drug

    FCX-013

    go.drugbank.com/drugs/DB18218
    Investigational

    FCX-013 consists of human dermal fibroblasts genetically modified with a lentiviral vector expressing metalloproteinase-1 (MMP-1).

  2. Drug

    Raxtozinameran

    go.drugbank.com/drugs/DB18228
    ApprovedInvestigational

    It works by binding to the spike (S) protein of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), which is a transmembrane glycoprotein that plays a vital role in viral pathogenesis, evolutions

    Synonyms: messenger RNA (mRNA), 5'-capped, encoding a full-length, codon-optimised pre-fusion stabilised conformation variant (K982P and V983P) of the SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2)
  3. Drug

    IBIO-100

    go.drugbank.com/drugs/DB18233
    Experimental

    IBIO-100 is a high molecular weight multimer of E3-Fc, an endostatin C-terminus and IgG1-Fc fusion protein.

  4. Drug

    CKD-504

    go.drugbank.com/drugs/DB18235
    Investigational

    CKD-504 is a novel, selective histone deacetylase 6 inhibitor.

  5. Drug

    DR-01

    go.drugbank.com/drugs/DB18258
    Investigational

    DR-01 is a monoclonal antibody directed against human CD94.

  6. Drug

    MRT5005

    go.drugbank.com/drugs/DB18260
    Investigational

    MRT5005 is a human cystic fibrosis transmembrane conductance regulator (hCFTR) messenger RNA (mRNA) complexed with branched polyethyleneimine (bPEI).

  7. Drug

    MPB-1523

    go.drugbank.com/drugs/DB18334
    Investigational

    MPB-1523 is a contrast agent comprising PEGylated iron oxide nanoparticles.[L48161]

  8. Drug

    HMI-204

    go.drugbank.com/drugs/DB18338
    Experimental

    HMI-204 is an adeno-associated virus serotype HSC15 expressing human arylsulfatase A

  9. Drug

    CN-105

    go.drugbank.com/drugs/DB18345
    Investigational

    CN-105 is a neuroprotective pentapeptide with the sequence Acetyl-Valine-Serine-Arginine-Arginine-Arginine-NH2 (Ac-VSRRR- NH2).

  10. Drug

    AMG-553

    go.drugbank.com/drugs/DB18346
    Investigational

    AMG-553 is an adoptive, anti-FLT3 chimeric antigen receptor T-cell therapy generated through transduction of autologous T-cells with a self-inactivating human immunodeficiency virus-1 based lentiviral